Clinical trial
Adjuvant Chemoradiation Therapy for Gastric or Gastroesophageal Junction…
NCT00215514 · Dana-Farber Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00215514 |
|---|---|
| Title | Adjuvant Chemoradiation Therapy for Gastric or Gastroesophageal Junction Adenocarcinoma |
| Official title | A Pilot Study of Adjuvant Chemoradiation After Resection of Gastric Or Gastroesophageal Junction Adenocarcinoma |
| Lead sponsor | Dana-Farber Cancer Institute, Other |
| Collaborators | Brigham and Women's Hospital Massachusetts General Hospital |
| Status | Completed |
| Phase | Early Phase 1 |
| Study type | Interventional |
| Conditions | Stomach Cancer, Gastric Cancer, Gastro-esophageal Junction Cancer |
| Intervention type | Drug, Procedure |
| Interventions | Epirubicin, Cisplatin, 5-Fluorouracil (5-FU), Radiation |
| Enrollment | 25 |
| Start date | Sep 1, 2000 |
| Primary completion | Nov 1, 2003 |
| Completion | Jul 1, 2014 |
| First posted | Sep 22, 2005 |
| Last update posted | Jul 29, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: